Stock WNT WNTRESEARCH AB
Add to a list
To use this feature you must be a member
Log inSign up

Company WntResearch AB

Equities

WNT

SE0022239901

Biotechnology & Medical Research

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 06:00:00 2024-07-10 pm EDT 		5-day change 1st Jan Change
16.29 SEK -3.04% Intraday chart for WntResearch AB +6.47% +77.07%
Jun. 20 WntResearch Presents Ad H Holes Observations from the NeoFox Study at ESMO GI CI
May. 03 WntResearch AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

WntResearch AB is a Sweden-based company engaged in the translational cancer research. Its aim is to develop anti-metastatic therapies based on an increased understanding of the mechanisms underlying the metastatic process and the evaluation of specific small molecules that can specifically interact with this process. The Company’s programs focus on the role of the Wnt-5a protein in the metastatic process. As of December 31, 2011, the Company had two projects, namely Foxy-5 and Box-5. Foxy-5 is a hexapeptide mimicking the effects of WNT-5a. Box-5 is a peptide antagonizing the effects of Wnt-5a. As of March 31, 2012, the Company’s largest shareholder was Forskarpatent I Syd AB, which held 26.55% shares.

Number of employees: 2

Managers

Managers TitleAgeSince
Per Norlén CEO
 Chief Executive Officer 54 Jan. 09
Tommy Evert Andersson FOU
 Founder 68 07-09-23
Anders Tidfors DFI
 Director of Finance/CFO - 20-09-10
Kicki Johansson COO
 Chief Operating Officer 66 17-12-31
Dennis Bang Henriksen CTO
 Chief Tech/Sci/R&D Officer 62 16-07-31
Klaus Christensen PRN
 Corporate Officer/Principal 56 18-12-31

Members of the board

Members of the board TitleAgeSince
Peter Jan Sture Ström BRD
 Director/Board Member 72 15-06-08
Tommy Evert Andersson FOU
 Founder 68 07-09-23
Christer Nordstedt CHM
 Chairman 62 21-12-31
Gudrun Anstrén BRD
 Director/Board Member 69 18-05-14
Janna Sand-Dejmek BRD
 Director/Board Member - -
Mats Lindskog BRD
 Director/Board Member - 22-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 8,660,590 1,309,629 ( 15.12 %) 0 15.12 %

Company contact information

WntResearch AB

Stora Södergatan 15

222 23, Lund

+

http://www.wntresearch.com
address WntResearch AB(WNT)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Quarterly revenue - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
WNTRESEARCH AB Stock WntResearch AB
+77.07% 13.8M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+20.95% 127B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+23.00% 116B
ARGENX SE Stock argenx SE
+25.15% 27.69B
BIONTECH SE Stock BioNTech SE
-19.75% 19.62B
GENMAB A/S Stock Genmab A/S
-16.57% 16.26B
BEIGENE, LTD. Stock BeiGene, Ltd.
-16.56% 15.49B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+11.19% 14.81B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-46.65% 14.39B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+57.74% 14.11B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. WNT Stock
  4. Company WntResearch AB